GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTyman Regulatory News (TYMN)

Share Price Information for Tyman (TYMN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 361.00
Bid: 361.00
Ask: 362.00
Change: -2.00 (-0.55%)
Spread: 1.00 (0.277%)
Open: 368.50
High: 368.50
Low: 359.00
Prev. Close: 363.00
TYMN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

10 May 2010 07:00

RNS Number : 5807L
Lupus Capital PLC
10 May 2010
 



Lupus Capital plc

("Lupus" or "the Company")

 

Appointment of Chief Financial Officer ("CFO")

 

Lupus announces that James Brotherton has today been appointed the Company's CFO and an Executive Director of the Company with effect from the conclusion of the Company's Annual General Meeting ("AGM") on 28 May 2010. Paul Felton-Smith, who has acted as interim CFO since July 2009, has today stepped down from the Board.

 

James joined Lupus in 2004 as Head of Corporate Development, and played an integral role in the Company's growth strategy through the acquisitions of Laird Group plc's Security Systems Division in 2007 and Schlegel Building Products in 2006. He was also extensively involved in the Company's successful refinancing announced in July 2009.

 

Prior to joining Lupus, James was a Director of UK Investment Banking at Citigroup in London, having previously worked in investment banking at HSBC. He qualified as a Chartered Accountant (ACA) with Ernst and Young in London.

 

Jamie Pike, Non-Executive Chairman of Lupus, commented:

 

"I am delighted that James has agreed to take up the role of Chief Financial Officer and look forward to the contribution he will make to the executive team and to the Group's businesses.

 

"We are grateful to Paul for all that he has done in his time as Finance Director, in particular in leading the finance function during a very difficult period."

 

 

Enquiries:

 

Lupus Capital plc

+44 (0)20 7976 8000

Jamie Pike (Non-Executive Chairman)

Collins Stewart Europe Limited

+44 (0)20 7523 8350

Mark Dickenson / Tom Hulme

College Hill

+44 (0)20 7457 2020

Mark Garraway / Adam Aljewicz

 

10 May 2010

 

2010 AGM

 

On 28 May 2010, James will attend the Company's 2010 AGM to support the Directors of the Company in his role as CFO.

 

The Company's 2010 AGM materials were posted to shareholders on 30 April 2010 and James' appointment was approved by the Board on 7 May 2010. It was therefore not practical to include a resolution in the notice of AGM in respect of James' election as a Director of the Company. His appointment as a Director of the Company is effective from the conclusion of the Company's 2010 AGM and he will be submitted for re-election at the Company's 2011 AGM.

 

 

Further information required by Rule 17 and Schedule 2(g) of the AIM Rules for Companies:

 

James Edward Brotherton (age 40)

 

Present directorships and/or partnerships:

 

None

 

Former directorships and/or partnerships (within the last five years):

 

Amesbury Acquisition Holdings Inc

Jasper Acquisition Holdings Limited

Jasper Acquisition Holdings (2) Limited

Jasper Acquisition Limited

Lupus Capital Jersey Limited

Lupus Capital Jersey (2) Limited

Schlegel Acquisition Holdings Limited

Schlegel Australia (2006) Pty. Limited

Schlegel (UK) 2006 Limited

 

Shareholdings in Lupus Capital plc at the date of this announcement:

 

Shareholding

Options over Ordinary Shares

number

%

number

%

James Brotherton

149,191

0.11

100,000

0.07

 

 

No further disclosures are required under Schedule 2(g) of the AIM Rules for Companies.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAQDLFBBEFFBBD
Date   Source Headline
15th Dec 202210:59 amRNSHolding(s) in Company
14th Dec 202212:00 pmRNSRefinancing of Debt Facilities
28th Nov 20223:30 pmRNSHolding(s) in Company
17th Nov 20227:00 amRNSTrading Statement
18th Oct 202212:00 pmRNSHolding(s) in Company
6th Oct 20223:41 pmRNSTR-1 Replacement: Notification of major holdings
5th Oct 20225:01 pmRNSHolding(s) in Company
5th Oct 20225:00 pmRNSHolding(s) in Company
5th Oct 20224:04 pmRNSHolding(s) in Company
19th Aug 20223:33 pmRNSHolding(s) in Company
1st Aug 20223:34 pmRNSHolding(s) in Company
26th Jul 20227:00 amRNSHalf-year Report
17th Jun 20224:23 pmRNSHolding(s) in Company
6th Jun 20228:08 amRNSDirector/PDMR Shareholding
24th May 20229:57 amRNSDirector/PDMR Shareholding
19th May 20224:41 pmRNSDirector/PDMR Shareholding
19th May 20224:40 pmRNSResult of AGM
19th May 20227:00 amRNSAGM Trading Update
26th Apr 20225:14 pmRNSHolding(s) in Company
25th Apr 20223:36 pmRNSHolding(s) in Company
20th Apr 20223:59 pmRNSDirector/PDMR Shareholding
11th Apr 202211:30 amRNSDirector/PDMR Shareholding
1st Apr 20224:00 pmRNSHolding(s) in Company
1st Apr 20227:00 amRNSNotice of AGM
31st Mar 20229:56 amRNSHolding(s) in Company
31st Mar 20229:51 amRNSHolding(s) in Company
29th Mar 20223:07 pmRNSHolding(s) in Company
29th Mar 202212:00 pmRNSEBT Purchase
29th Mar 202210:54 amRNSHolding(s) in Company
15th Mar 20227:00 amRNSRefinancing of US Private Placement Notes
10th Mar 20223:12 pmRNSDirector/PDMR Shareholding
10th Mar 20222:43 pmRNSHolding(s) in Company
8th Mar 202212:09 pmRNSHolding(s) in Company
3rd Mar 20223:21 pmRNSDirector/PDMR Shareholding
3rd Mar 20227:00 amRNSFinal Results
22nd Feb 20224:10 pmRNSNotice of Results
25th Jan 202210:05 amRNSDirector Declaration
16th Dec 20217:00 amRNSNew Non-Executive Director
25th Nov 202112:57 pmRNSTotal Voting Rights
17th Nov 20217:00 amRNSTrading Update
28th Oct 20219:43 amRNSHolding(s) in Company
14th Sep 20217:49 amRNSHolding(s) in Company
13th Aug 202110:21 amRNSChange of Auditor
30th Jul 20213:28 pmRNSHolding(s) in Company
27th Jul 20217:00 amRNSHalf-year Report
2nd Jun 202112:06 pmRNSHolding(s) in Company
2nd Jun 202112:00 pmRNSHolding(s) in Company
1st Jun 20214:12 pmRNSHolding(s) in Company
1st Jun 20213:53 pmRNSHolding(s) in Company
25th May 20215:30 pmRNSRSA Insurance Group

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.